The global cell-based assay market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period. The increasing technological-based advancement by key players operating in the market and various approval for assays-based products are key factors that are propelling the market growth. The companies are investing in the development of new and technology-based products such as AI, Cloud-based new products, and other technologies that are fulfilling the increasing demand by the end-user of the market. For instance,
Browse the full report description of “Cell-based Assays Market Size, Share & Trends Analysis Report by Product (Consumable, Instruments, and Software & Services), by Application (Drug Discovery, Basic Research, ADME Studies, and Predictive Toxicology), and by End-User (Contract Research Organizations, Academic and Government Institutions, and Pharmaceutical and Biotechnology Companies) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/cell-based-assay-market
• In August 2022, Predicine company launched its CE-marked "PredicineCARE" liquid biopsy assay in Europe which is to target 152 genes in patients diagnosed with cancer. This liquid biopsy assay has been used in patient testing, clinical trials, and in the development of companion diagnostics.
• In March 2022, CELLINK, a BICO Company, launched BIO CELLX, to eliminate barriers to automating 3D cell-based assays targeting cancer research and drug discovery. This new system that automates 3D cell culture workflows is built upon CELLINK’s impressive bioprinting portfolio which utilizes many proven technologies. The new system was selected as a finalist for the New Product Award at the recent SLAS conference in Boston.
• In February 2021, Axion BioSystems has launched Maestro ZHT a screening platform, to add a new dimension to drug discovery and development by leveraging their expertise in live-cell instrumentation. This new platform meets all the changes such as reducing cost, time, and waste of precious antibodies and cells with an easy, automated, real-time, live-cell assay.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape includes Becton, Dickinson and Co., Corning Inc., Eurofins DiscoverX Products, LLC, General Electric Co., Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Cell-based Assays Market Report Segment
By Product
• Consumables
o Reagents
o Cell Lines
o Microplates
o Probes & Labels
By Application
By End-User
Global Cell-based Assays Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cell-based-assay-market